Sapiens International Corporation N.V. (SPNS)
USD 27.78
(-2.83%)
USD 27.78
(-2.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 79.42 Million | 43.78 Million | 80.54 Million | 58.25 Million | 66.15 Million | 27.7 Million |
| Net Income | 62.44 Million | 52.93 Million | 47.32 Million | 34.15 Million | 26.49 Million | 14 Million |
| Depreciation & Amortization | 15.66 Million | 22.24 Million | 28.66 Million | 23.38 Million | 19.13 Million | 19.86 Million |
| Deferred income taxes | -34.56 Million | -10.13 Million | 1.37 Million | 395 Thousand | -40 Thousand | -194 Thousand |
| Stock-based compensation | 3.62 Million | 3.83 Million | 4.71 Million | 3.98 Million | 1.4 Million | 1.94 Million |
| Change in working capital | -8.76 Million | -35.46 Million | -1.73 Million | -3.8 Million | 18.99 Million | -8.1 Million |
| Other non-cash items | 41.02 Million | 10.24 Million | 106 Thousand | 134 Thousand | 171 Thousand | 194 Thousand |
| Investing Cash Flow | -72.94 Million | -12.44 Million | 125 Thousand | -114.6 Million | -41.86 Million | -25.58 Million |
| Investments in PPE | -9.26 Million | -9.05 Million | -11.84 Million | -11.24 Million | -17.13 Million | -7.07 Million |
| Acquisitions | -8.17 Million | -3.46 Million | 831 Thousand | -95.86 Million | -1.55 Million | -18.5 Million |
| Investment purchases | -55.49 Million | - | 8.06 Million | -30.39 Million | -24 Million | - |
| Sales/Maturities of investments | 62.14 Million | 26 Thousand | 10.03 Million | -8.59 Million | 18.05 Million | - |
| Other Investing Activities | -62.14 Million | 54 Thousand | -6.95 Million | 31.49 Million | -17.22 Million | -5.16 Million |
| Financing Cash Flow | -43.33 Million | -58.37 Million | -39.96 Million | 143.32 Million | -20.65 Million | -9.42 Million |
| Debt repayment | -19.79 Million | -19.79 Million | -19.79 Million | -29.89 Million | -9.9 Million | -237 Thousand |
| Dividends payments | -28.14 Million | -38.57 Million | -20.25 Million | -7.04 Million | -11 Million | -9.97 Million |
| Common Stock Repurchased | - | - | -2.03 Million | 85.39 Million | -780 Thousand | - |
| Common Stock Issuance | 4.8 Million | - | 2.03 Million | 108.73 Million | 780 Thousand | 895 Thousand |
| Other Financing Activities | 4.6 Million | -19.79 Million | 91 Thousand | -13.87 Million | 257 Thousand | 787 Thousand |
| Accounts receivables | 3.96 Million | -21.86 Million | -13.93 Million | -5.16 Million | 10.51 Million | -7.58 Million |
| Accounts payables | -3.58 Million | 4.63 Million | -529 Thousand | -1.34 Million | -1.47 Million | -1.87 Million |
| Inventory | - | - | 13.93 Million | 5.16 Million | 13.39 Million | 529 Thousand |
| Other working capital | -9.14 Million | -18.23 Million | -1.2 Million | -2.45 Million | -3.43 Million | 825 Thousand |
| Cash at beginning of period | 160.28 Million | 190.24 Million | 152.56 Million | 66.29 Million | 64.62 Million | 71.46 Million |
| Cash at end of period | 126.71 Million | 160.28 Million | 190.24 Million | 152.56 Million | 66.29 Million | 64.62 Million |
| Capital Expenditure | -9.26 Million | -9.05 Million | -11.84 Million | -11.24 Million | -17.13 Million | -7.07 Million |
| Effect of forex changes on cash | 3.12 Million | -2.92 Million | -3.02 Million | -707 Thousand | -1.96 Million | 470 Thousand |
| Net cash flow / Change in cash | -33.56 Million | -29.95 Million | 37.68 Million | 86.26 Million | 1.66 Million | -6.83 Million |
| Free Cash Flow | 70.15 Million | 34.72 Million | 68.69 Million | 47.01 Million | 49.01 Million | 20.62 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 18.61 Million | 17.36 Million | 16.97 Million | 62.44 Million | 16 Million | 15.47 Million |
| Depreciation & Amortization | 3.12 Million | 4.1 Million | 5.65 Million | 15.66 Million | 5.04 Million | 5.33 Million |
| Deferred income taxes | - | - | -2.57 Million | -34.56 Million | -3000.00 | 96 Thousand |
| Stock-based compensation | 811 Thousand | 772 Thousand | 661 Thousand | 3.62 Million | 1.03 Million | 1.05 Million |
| Change in working capital | -15.41 Million | -5.44 Million | 14.73 Million | -8.76 Million | -18.11 Million | -7.37 Million |
| Other non-cash items | 5.29 Million | 21.84 Million | 1.7 Million | 41.02 Million | 15 Thousand | 18 Thousand |
| Investing Cash Flow | 11.5 Million | -8.57 Million | -9.72 Million | -72.94 Million | 12.28 Million | -27.45 Million |
| Investments in PPE | -2.46 Million | -2.18 Million | -1.87 Million | -9.26 Million | -2.34 Million | -2.46 Million |
| Acquisitions | -1.36 Million | -3.09 Million | -7.92 Million | -8.17 Million | 9221.06 | 10.51 Thousand |
| Investment purchases | 3.29 Million | -3.29 Million | 81.56 Thousand | -55.49 Million | 14.62 Million | -24.99 Million |
| Sales/Maturities of investments | 12.03 Million | - | 1.65 Million | 62.14 Million | -9221.06 | -10.51 Thousand |
| Other Investing Activities | 13.61 Million | -5 Million | -1.65 Million | -62.14 Million | 10 Thousand | 11 Thousand |
| Financing Cash Flow | -15.24 Million | -19.79 Million | -107 Thousand | -43.33 Million | -9.59 Million | -13.79 Million |
| Debt repayment | -162.23 Thousand | -19.79 Million | -70.54 Thousand | -19.79 Million | -305.96 Thousand | -318.11 Thousand |
| Dividends payments | -15.5 Million | - | -100.29 Thousand | -28.14 Million | -13.68 Million | -13.57 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 97.19 Thousand | - | 35.15 Thousand | 4.8 Million | 4.6 Million | - |
| Other Financing Activities | -1.03 Million | -3.09 Million | -107 Thousand | 4.6 Million | 4.75 Million | 755.27 |
| Accounts receivables | 2.08 Million | -14.7 Million | 12.24 Million | 3.96 Million | -11.04 Million | 4.35 Million |
| Accounts payables | 862.56 Thousand | 3.54 Million | -2.85 Million | -3.58 Million | 398 Thousand | 6 Million |
| Inventory | - | - | - | - | -1.25 Million | -4.35 Million |
| Other working capital | -18.35 Million | 5.7 Million | 5.34 Million | -9.14 Million | -6.2 Million | -13.37 Million |
| Cash at beginning of period | 116.68 Million | 126.71 Million | 97.06 Million | 160.28 Million | 89.41 Million | 116.65 Million |
| Cash at end of period | 122.64 Million | 116.68 Million | 126.71 Million | 126.71 Million | 97.06 Million | 89.41 Million |
| Capital Expenditure | -2.46 Million | -2.18 Million | -1.87 Million | -9.26 Million | -2.34 Million | -2.46 Million |
| Effect of forex changes on cash | 1.41 Million | -147 Thousand | 1.26 Million | 3.12 Million | 960 Thousand | -592 Thousand |
| Net cash flow / Change in cash | 5.95 Million | -10.02 Million | 29.65 Million | -33.56 Million | 7.64 Million | -27.23 Million |
| Free Cash Flow | 5.86 Million | 16.3 Million | 35.26 Million | 70.15 Million | 1.64 Million | 12.13 Million |
BIOCQ
ASND
002199
HTCMF
AYA
NER